Cargando…

Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies

Fcγ receptors (FcγRs) bind the constant Fc region of IgG molecules. IgG/antigen-containing immune complexes elicit a variety of effector functions in cells that express activating FcγRs. Because activating FcγRs are present on cells from the innate immune system, such as dendritic cells, monocytes/m...

Descripción completa

Detalles Bibliográficos
Autor principal: van Roon, Joel AG
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206374/
https://www.ncbi.nlm.nih.gov/pubmed/17764583
http://dx.doi.org/10.1186/ar2224
_version_ 1782148456794554368
author van Roon, Joel AG
author_facet van Roon, Joel AG
author_sort van Roon, Joel AG
collection PubMed
description Fcγ receptors (FcγRs) bind the constant Fc region of IgG molecules. IgG/antigen-containing immune complexes elicit a variety of effector functions in cells that express activating FcγRs. Because activating FcγRs are present on cells from the innate immune system, such as dendritic cells, monocytes/macrophages and granulocytes, these IgG receptors form a crucial link between the innate and the acquired immune systems. Recently, the ability to detect the inhibitory FcγRIIb on cells has indicated an imbalance between activating and inhibitory FcγRs in rheumatoid arthritis. This progress offers an opportunity to study modulation of FcγR balance and could stimulate development of FcγR-directed immunotherapy.
format Text
id pubmed-2206374
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22063742008-01-19 Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies van Roon, Joel AG Arthritis Res Ther Editorial Fcγ receptors (FcγRs) bind the constant Fc region of IgG molecules. IgG/antigen-containing immune complexes elicit a variety of effector functions in cells that express activating FcγRs. Because activating FcγRs are present on cells from the innate immune system, such as dendritic cells, monocytes/macrophages and granulocytes, these IgG receptors form a crucial link between the innate and the acquired immune systems. Recently, the ability to detect the inhibitory FcγRIIb on cells has indicated an imbalance between activating and inhibitory FcγRs in rheumatoid arthritis. This progress offers an opportunity to study modulation of FcγR balance and could stimulate development of FcγR-directed immunotherapy. BioMed Central 2007 2007-08-20 /pmc/articles/PMC2206374/ /pubmed/17764583 http://dx.doi.org/10.1186/ar2224 Text en Copyright © 2007 BioMed Central Ltd
spellingShingle Editorial
van Roon, Joel AG
Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies
title Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies
title_full Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies
title_fullStr Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies
title_full_unstemmed Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies
title_short Activating and inhibitory Fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies
title_sort activating and inhibitory fcγ receptors in rheumatoid arthritis: from treatment to targeted therapies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206374/
https://www.ncbi.nlm.nih.gov/pubmed/17764583
http://dx.doi.org/10.1186/ar2224
work_keys_str_mv AT vanroonjoelag activatingandinhibitoryfcgreceptorsinrheumatoidarthritisfromtreatmenttotargetedtherapies